187 related articles for article (PubMed ID: 26138524)
1. Arginine-rich histones have strong antiviral activity for influenza A viruses.
Hoeksema M; Tripathi S; White M; Qi L; Taubenberger J; van Eijk M; Haagsman H; Hartshorn KL
Innate Immun; 2015 Oct; 21(7):736-45. PubMed ID: 26138524
[TBL] [Abstract][Full Text] [Related]
2. Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D.
Hsieh IN; White M; Hoeksema M; Deluna X; Hartshorn K
PLoS One; 2021; 16(2):e0247605. PubMed ID: 33635872
[TBL] [Abstract][Full Text] [Related]
3. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.
White MR; Kandel R; Tripathi S; Condon D; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2014; 9(7):e101364. PubMed ID: 24988208
[TBL] [Abstract][Full Text] [Related]
5. Differential mode of antimicrobial actions of arginine-rich and lysine-rich histones against Gram-positive Staphylococcus aureus.
Morita S; Tagai C; Shiraishi T; Miyaji K; Iwamuro S
Peptides; 2013 Oct; 48():75-82. PubMed ID: 23932939
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial properties of arginine- and lysine-rich histones and involvement of bacterial outer membrane protease T in their differential mode of actions.
Tagai C; Morita S; Shiraishi T; Miyaji K; Iwamuro S
Peptides; 2011 Oct; 32(10):2003-9. PubMed ID: 21930170
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses.
Nayak MK; Agrawal AS; Bose S; Naskar S; Bhowmick R; Chakrabarti S; Sarkar S; Chawla-Sarkar M
J Antimicrob Chemother; 2014 May; 69(5):1298-310. PubMed ID: 24458510
[TBL] [Abstract][Full Text] [Related]
8. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain.
van Eijk M; White MR; Crouch EC; Batenburg JJ; Vaandrager AB; Van Golde LM; Haagsman HP; Hartshorn KL
J Immunol; 2003 Aug; 171(3):1431-40. PubMed ID: 12874235
[TBL] [Abstract][Full Text] [Related]
9. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
Hsu SF; Su WC; Jeng KS; Lai MM
J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
Nacken W; Ehrhardt C; Ludwig S
Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
[TBL] [Abstract][Full Text] [Related]
11. Histone release during transcription: NAP1 forms a complex with H2A and H2B and facilitates a topologically dependent release of H3 and H4 from the nucleosome.
Levchenko V; Jackson V
Biochemistry; 2004 Mar; 43(9):2359-72. PubMed ID: 14992573
[TBL] [Abstract][Full Text] [Related]
12. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J
PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.
Zhou A; Dong X; Liu M; Tang B
Front Immunol; 2021; 12():632798. PubMed ID: 34367124
[TBL] [Abstract][Full Text] [Related]
14. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
15. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.
Londrigan SL; Short KR; Ma J; Gillespie L; Rockman SP; Brooks AG; Reading PC
J Virol; 2015 Dec; 89(24):12319-29. PubMed ID: 26423941
[TBL] [Abstract][Full Text] [Related]
16. Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism.
Woo HM; Kim KS; Lee JM; Shim HS; Cho SJ; Lee WK; Ko HW; Keum YS; Kim SY; Pathinayake P; Kim CJ; Jeong YJ
Antiviral Res; 2013 Nov; 100(2):337-45. PubMed ID: 24055449
[TBL] [Abstract][Full Text] [Related]
17. Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19.
Hartshorn KL
Front Cell Infect Microbiol; 2020; 10():563850. PubMed ID: 33194802
[TBL] [Abstract][Full Text] [Related]
18. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
[TBL] [Abstract][Full Text] [Related]
19. Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro.
Tang C; Carrera Montoya J; Fritzlar S; Flavel M; Londrigan SL; Mackenzie JM
Virology; 2024 Feb; 590():109969. PubMed ID: 38118269
[TBL] [Abstract][Full Text] [Related]
20. Complexes of DNA with arginine-rich and slightly lysine-rich histones. Transcription and electron microscopy.
Weihe A; von Mickwitz CU; Grade K; Lindigkeit R
Biochim Biophys Acta; 1978 Mar; 518(1):172-6. PubMed ID: 629975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
